Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002010977 | SCV002291143 | likely pathogenic | not provided | 2021-05-13 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that this variant is associated with skipping of exon and retention of intron, which introduces a premature termination codon (PMID:15921385). The resulting mRNA is expected to undergo nonsense-mediated decay. This variant has been observed in individual(s) withcongenital methemoglobinemia (PMID: 15921385). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 6 of the CYB5R3 gene. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. |
Revvity Omics, |
RCV003485758 | SCV004238134 | likely pathogenic | Deficiency of cytochrome-b5 reductase | 2023-02-27 | criteria provided, single submitter | clinical testing |